Skip to main content
Premium Trial:

Request an Annual Quote

Clarification: Oct 1, 2003

Premium

CLARIFICATION — In the BioArray News article, “Mike Hunkapiller, ABI, Stay Mum On Details of its Expression Array System,” published on Sept. 24, 2003, reported that Applied Biosystems President Mike Hunkapiller said the company’s patent, US Patent No. 6,573,089, “Method for using and making a fiber array,” referred to a next-generation microarray. In fact, in a later discussion, a company spokeswoman said Hunkapiller was referencing the company’s announced Expression Array System as next-generation microarray technology — not the technology described in US Patent No. 6,573,089. “Patent No. 6,573,089 is not for a next-generation microarray technology,” a company spokeswoman said in an e-mail message. BioArray News is pleased to make the clarification.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.